MiR-662 impairs C/D box snoRNA expression and rRNA 2′-O-ribose methylation marks
MiR-662 overexpression has been reported to promote breast cancer metastatic progression and to impair the expression of genes encoding for proteins involved in translation, ribosome biogenesis and ribosome processing (Puppo et al., 2023); however, the relationship between miR-662 and the translational machinery was no...